Amgen (AMGN) stock slid more than 4.5% at the start of Wednesday trading after the pharmaceutical giant reported the results of several drug trials.
Amgen (AMGN) stock slid more than 4.5% at the start of Wednesday trading after the pharmaceutical giant reported the results of several drug trials.
The House just passed a continuing resolution to fund the government until...
ByglobalreutersSeptember 25, 2024US sells 5-year notes at 3.519% vs 3.519% WIRussian Putin: Current military...
ByglobalreutersSeptember 25, 2024Federal Reserve Governor Kugler speaking in Q&A nowWe're at a place where...
ByglobalreutersSeptember 25, 2024UBS cite various supply and demand factors for their forecast. Beginning with...
ByglobalreutersSeptember 25, 2024
Leave a comment